Dopamine d2 Receptor anticorps

N° du produit ABIN1450212

Détail du produit anti-Dopamine d2 Receptor anticorps

Antigène: Dopamine d2 Receptor (DRD2) (Dopamine Receptor D2 (DRD2))

Reactivité: Humain, Rat, Souris

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp Dopamine d2 Receptor est non-conjugé

Application: Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Specificité: Reacts with Human Dopamine Receptor D2 (family: GPCR, subfamily: Dopamine). BLAST analysis of the peptide immunogen showed no homology with other Human proteins, except ZNF57 (42 %).

Réactivité croisée (Details): Species reactivity (expected):Mouse and Rat.
Species reactivity (tested):Human.

Purification: Immunoaffinity Chromatography

Information d'application

Indications d'application: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Stockage

Concentration: 1.0 mg/mL

Buffer: PBS, 0.09 % Sodium Azide

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Détails sur Dopamine d2 Receptor

Antigène: Dopamine d2 Receptor (DRD2) (Dopamine Receptor D2 (DRD2))

Autre désignation: Dopamine D2 Receptor (DRD2 Produits)

Synonymes: anticorps D2DR, anticorps D2R, anticorps drd2b, anticorps d2r2, anticorps Drd-2, anticorps d2dr, anticorps d2r, anticorps drd2, anticorps drd2-B, anticorps DRD2, anticorps D2, anticorps CG18741, anticorps CG7569, anticorps DAMB, anticorps DDR2, anticorps DOPR2, anticorps DOPR99B, anticorps Dar2, anticorps Dmel\\CG18741, anticorps DopD1, anticorps DopR99B, anticorps DopRII, anticorps dopamine receptor D2, anticorps dopamine receptor D2 like, anticorps dopamine receptor D2 L homeolog, anticorps dopamine receptor D2 S homeolog, anticorps Dopamine 1-like receptor 2, anticorps DRD2, anticorps drd2l, anticorps drd2, anticorps Drd2, anticorps drd2.L, anticorps drd2.S, anticorps Dop1R2

Sujet: The DRD2 Dopamine Receptor is involved in the neuromodulation of appetitive behaviors. DRD2 may be linked to alcoholism and other substance-use disorders. Mutations in DRD2 in mice lead to the suppression of reward behavior with morphine and to the reduction of spontaneous movements, a phenotype resembling Parkinson's disease. Three alternatively spliced isoforms have been identified. DRD2 has been reported to be expressed in various regions of the brain, as well as in aorta, artery, eye, and spinal cord. ESTs have been isolated from normal pituitary and in brain, colon, lung, pancreas, and skeletal muscle cancer libraries.Synonyms: D(2) dopamine receptor, DRD2

ID gène: 1813

Pathways: Positive Regulation of Peptide Hormone Secretion, Negative Regulation of Hormone Secretion, cAMP Metabolic Process, Inositol Metabolic Process, Regulation of G-Protein Coupled Receptor Protein Signaling, Feeding Behaviour, Negative Regulation of Transporter Activity, Regulation of long-term Neuronal Synaptic Plasticity